Supernus Pharmaceuticals (SUPN) Work In Process (2013 - 2026)
Supernus Pharmaceuticals' Work In Process was $27.16 million in Q2 2026, up 73.6% from $15.65 million a year earlier but down 24.7% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Work In Process (2013 - 2026) Analysis & Trends
At the end of FY2025, Work In Process at Supernus Pharmaceuticals came in at $29.44 million, up 10.1% from FY2024.
- Work In Process shows a five-year compound annual growth rate of 26.8% (FY2020 to FY2025).
- In earlier years, Work In Process was $26.73 million in FY2024 (-14.4%), $31.21 million in FY2023 (-1.6%), $31.71 million in FY2022 (-30.6%) and $45.71 million in FY2021 (+408.7%).
- Quarterly Work In Process has moved between $15.65 million (Q2 2025) and $46.22 million (Q1 2022) over five years.
- Compared with a year earlier, Work In Process has increased for four straight quarters, with growth averaging 16.5% over the last eight quarters.
- The best year-over-year quarter for Work In Process over five years was Q4 2021 (growth of 408.7%); the worst was Q2 2023 (a decline of 36.0%).
- Per Business Quant data, SUPN's Work In Process in the three quarters before Q2 2026 was $36.05 million (Q1 2026), $29.44 million (Q4 2025) and $33.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.16 Mn |
| Mar 31, 2026 | 36.05 Mn |
| Dec 31, 2025 | 29.44 Mn |
| Sep 30, 2025 | 33.41 Mn |
| Jun 30, 2025 | 15.65 Mn |
| Mar 31, 2025 | 18.69 Mn |
| Dec 31, 2024 | 26.73 Mn |
| Sep 30, 2024 | 28.10 Mn |
| Jun 30, 2024 | 23.59 Mn |
| Mar 31, 2024 | 23.25 Mn |
| Dec 31, 2023 | 31.21 Mn |
| Sep 30, 2023 | 26.97 Mn |
| Jun 30, 2023 | 23.59 Mn |
| Mar 31, 2023 | 33.98 Mn |
| Dec 31, 2022 | 31.71 Mn |
| Sep 30, 2022 | 25.46 Mn |
| Jun 30, 2022 | 36.86 Mn |
| Mar 31, 2022 | 46.22 Mn |
| Dec 31, 2021 | 45.71 Mn |
| Sep 30, 2021 | 37.91 Mn |
API Access
Supernus Pharmaceuticals Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();